Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb:48:91-103.
doi: 10.1016/j.semcancer.2017.04.015. Epub 2017 May 2.

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

Jake S O'Donnell  1 , Daniela Massi  2 , Michele W L Teng  3 , Mario Mandala  4
Affiliations
Review

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

Jake S O'Donnell et al. Semin Cancer Biol. 2018 Feb.

Abstract

Cancer therapies will increasingly be utilized in combination to treat advanced malignancies so as to increase their long-term efficacy in a greater proportion of patients. In particular, much attention has focused on developing targeted therapies that inhibit the PI3K-AKT-mTOR signaling network which is dysregulated in many cancer types. In addition, there is now a growing appreciation that targeting of these pathways can impact not only on cancer cells, but also host immunity. The clinical success of cancer immunotherapies targeting T-cell immune checkpoint receptors PD-1/PD-L1 has demonstrated the importance of immunoevasion as a hallmark of cancer. In this review, we discuss how PI3K-AKT-mTOR inhibitors target cancer cell biology, attenuate immune cell effector function and modulate the tumor microenvironment. We next discuss how the immunomodulatory potential of these inhibitors can be exploited through rational combinations with immunotherapies and targeted therapies.

Keywords: AKT; Combination therapy; Immunotherapeutic resistance; Immunotherapy; Inhibitors; PI3K; Targeted therapy; Tumor microenvironment; mTOR.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances

LinkOut - more resources